Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 7, 1999, Pages 719-728

  Bilak, Masako M ^a   Corse, Andrea M ^a   Bilak, Stephan R ^a   Lehar, Mohamed ^a   Tombran Tink, Joyce ^b   Kuncl, Ralph W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Glutamate toxicity; Motor neuron disease; Neurotrophic factor; PEDF; Serpin; Spinal cord; Tissue culture

Indexed keywords

CHOLINE ACETYLTRANSFERASE; GLUTAMIC ACID; MESSENGER RNA; NEUROPROTECTIVE AGENT; PIGMENT EPITHELIUM DERIVED FACTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MONKEY; NERVE DEGENERATION; NEUROPROTECTION; NEWBORN; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SPECIES DIFFERENCE; SPINAL CORD MOTONEURON; TISSUE DISTRIBUTION;

EID: 0032796456     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199907000-00006     Document Type: Article

References (51)

1. Oppenheim RW, Yin QW, Prevette D, Yan Q. Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 1992;360:755-57
2. Koliatsos VE, Cayouette MH, Berkemeier LR, Clatterbuck RE, Price DL, Rosenthal A. Neurotrophin 4/5 is a trophic factor for mammalian facial neurons. Proc Natl Acad Sci USA 1994;91: 3304-8
3. Zurn AD, Baetge EE, Hammang JP, Tan SA, Aebischer P. Glial cell line-derived neurotrophic factor, a new neurotrophic factor for motoneurons. NeuroReport 1994;6:113-18
4. Mattson MP, Murrain M, Guthrie PB, Kater, SB. Fibroblast growth factor and glutamate: Opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J Neurosci 1989;9:3728-40
5. Schubert D, Kimura H, Maher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci USA 1992;89:8264-67
6. Plaitakis A. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: A hypothesis. Ann Neurol 1990;28:3-8
7. Young AB. What's the excitement about excitatory amino acids in amyotrophic lateral sclerosis? Ann Neurol 1990;28:9-11
8. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992;326:1464-68
9. Rothstein JD, Van Kammen M, Levey AI, Martin L, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84
10. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993;90:6591-95
11. Corse AM, Rothstein JD. Organotypic spinal cord cultures and a model of chronic glutamate-mediated motor neuron degeneration. In: Ohnishi ST, Ohnishi T, eds. Membrane-linked diseases - CNS trauma: laboratory techniques and recent advancement. Philadelphia: CRC Press, 1995:341-51
12. Tombran-Tink J, Chader GJ, Johnson LV. A pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991;53:411-14
13. Ortego J, Escribano J, Becerra SP, Coca-Prados M. Gene expression of the neurotrophic pigment epithelium-derived factor in the human ciliary epithelium. Invest Ophthal Vis Sci 1996;37:2759-67
14. Tombran-Tink J, Shivaram SM, Chader GJ, Johnson LV, Bok D. Expression, secretion, and age-related downregulation of pigment epithelial-derived factor, a serpin with neurotrophic activity. J Neurosci 1995;15:4992-5003
15. Wu YQ, Notario V, Chader GJ, Becerra SP. Identification of pigment epithelial-derived factor in the interphotoreceptor matrix of bovine eyes. Protein Expr Purif 1995;6:447-56
16. Tombran-Tink J, Mazuruk K, Rodriguez IR, et al. Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelial-derived factor, a unique neurotrophic serpin. Mol Vis 1996;2:1-12
17. Steele FR, Chader GJ, Johnson LV, Tombran-Tink J. Pigment epithelium-derived factor (PEDF): Neurotrophic activity and identification as a unique member of the serine protease inhibitor (SERPIN) gene family. Proc Natl Acad Sci USA 1993;90:1526-30
18. Taniwaki T, Becerra SP, Chader GJ, Schwartz JP. Pigment epithelial-derived factor is a surviving factor for cerebellar granule cells in culture. J Neurochem 1995;64:2509-17
19. Taniwaki T, Hirashima N, Becerra SP, Chader GJ, Etcheberrigaray R, Schwartz JP. Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity. J Neurochem 1997;68:26-32
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-85
21. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-54
22. o State. J Biol Chem 1993;268:8949-57
23. Olney JW. Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. J Neuropathol Exp Neurol 1971;30:75-90
24. Burnett AL, Saito S, Maguire MP, Yamaguchi H, Chang TS, Hanley DF. Localization of nitric oxide synthase in spinal nuclei innervating pelvic ganglia. J Urol 1995;153:212-17
25. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 1975;24:407-9
26. Phelps PE, Barber RP, Houser CR, Crawford GD, Salvaterra PM, Vaughn JE. Postnatal development of neurons containing choline acetyltransferase in rat spinal cord: An immunocytochemical study. J Comp Neurol 1984;229:347-61
27. Armstrong DM, Brady R, Hersh LB, Hayes RC, Wiley RG. Expression of choline acetyltransferase and nerve growth factor receptor within hypoglossal motoneuron following nerve injury. J Comp Neurol 1991;304:596-607
28. Sternberger LA, Sternberger NH. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA 1983;80:6126-30
29. Campbell MJ, Morrison JH. Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J Comp Neurol 1989;282:191-205
30. Rothstein JD, Kuncl RW. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 1995;65:643-51
31. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in ALS. Lancet 1996;347:1425-31
32. Miller RG, Moore D, Young LA, et al. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS study group. Neurology 1996;47:1383-88
33. Lai EC, Felice KJ, Festoff BW, et al. Effect of recombinant human insulin-like growth factor-I on progression of ALS. Neurology 1997;49:1621-30
34. ALS CNTF Treatment Study [ACTS] Group. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 1996;46:1244-49
35. Cedarbaum JM, Stambler N, Brooks BR, Bradley W. Brain-derived neurotrophic factor in amyotrophic lateral sclerosis: A failed drug or a failed trial? Ann Neurol 1998;44:506-7
36. Sendtner M, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 1990;345:440-41
37. Koliatsos VE, Clatterbuck RE, Winslow JW, Cavouette MH, Price DL. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 1993;10:359-67
38. Mitsumoto H, Ikeda K, Klinkosz B, Cedarbaum JM, Wong V, Lindsay RM. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF Science 1994;265:1107-10
39. Oppenheim RW. The absence of significant postnatal motoneuron death in the brachial and lumbar spinal cord of the rat. J Comp Neurol 1986;246:281-86
40. Li L, Oppenheim RW, Lei M, Houenou LJ. Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. J Neurobio 1994;25:759-66
41. Baker JB, Low DA, Simmer RL, Cunningham DD. Protease-nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 1980;21:37-45
42. Sommer J, Gloor SM, Rovelli GF, et al. cDNA sequence coding for a rat glia-derived nexin and its homology to members of the serpin superfamily. Biochem 1987;26:6407-10
43. Brenneman DE, Phillips TM, Festoff BW, Gozes I. Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide. Ann NY Acad Sci 1987;814:167-73
44. Houenou LJ, Turner PL, Li L, Oppenheim RW, Festoff BW. A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy-induced cell death. Proc Natl Acad Sci USA 1995;92:895-99
45. Zurn AD, Nick H, Monard D. A glia-derived nexin promotes neurite outgrowth in cultured chick sympathetic neurons. Dev Neurosci 1988;10:17-24
46. Monard D. Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. Trends Neurosci 1988;11:541-44
47. Festoff BW, Nelson PG, Brenneman DE. Prevention of activity-dependent neuronal death: Vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I. J Neurobiol 1996;30:255-66
48. Becerra SP, Sagasti A, Spinella P, Notario V. Pigment epithelium-derived factor behaves like a noninhibitory serpin. J Biol Chem 1995;270:25992-99
49. Sugita Y, Becerra SP, Chader GJ, Schwartz JP. Pigment epithelial-derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes. J Neurosci Res 1997;49:710-18
50. Alberdi E, Notario V, Becerra SP. PEDF-binding to retinal cells: Characterization of a candidate receptor for the neurotrophic factor PEDF [abstract]. Keystone meeting: Specificity in signal transduction, held in Lake Tahoe, NV. March 1-7, 1998:66
51. Alberdi E, Hyde CC, Becerra SP. PEDF binds to glycosaminoglycans: Analysis of binding site. Biochemistry 1998;37:10643-52